Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Clinical trial NCT01399840 · COMPLETED

Trial details

NCT number: NCT01399840
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome Chronic Lymphocytic Leukemia Mantle Cell Lymphoma

Start date: 2011-06-30
Primary completion: 2014-03-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.